Results

Chimerix Inc.

11/19/2021 | Press release | Distributed by Public on 11/19/2021 06:08

Chimerix Announces Positive ONC201 Data in Recurrent H3 K27M-mutant Diffuse Midline Glioma to Be Presented at the Society for Neuro-Oncology Annual Meeting